Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2007
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
, B Besse
Revue De Pneumologie Clinique
|
July 23, 2011
[What is the best sequence of treatment for patients with EGFR mutations?]
B Besse, G Zalcman
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?
V Polo, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2014
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
C Leduc, B Besse
Revue Des Maladies Respiratoires
|
February 24, 2015
[Targeted therapies in non-small cell lung cancer in 2014]
C Leduc, B Besse
Bulletin Du Cancer
|
July 28, 2010
[Internet as a tool in oncology: critical analysis]
B Rousseau, B Besse,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2014
Pharmacogenomics in NSCLC: mostly unsexy but desperately needed
B Besse, M Reck
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Developments in the treatment of early NSCLC: when to use chemotherapy
B Besse, T Le Chevalier
Bulletin Du Cancer
|
December 26, 2009
[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value]
D Planchard, Y Loriot, B Besse
Bulletin Du Cancer
|
May 13, 2009
[Targeting of the AKT-mTOR pathway in head and neck and lung cancer]
S Vignot, S Haberer, B Besse
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2007
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
, B Besse
Revue De Pneumologie Clinique
|
July 23, 2011
[What is the best sequence of treatment for patients with EGFR mutations?]
B Besse, G Zalcman
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Maintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?
V Polo, B Besse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2014
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
C Leduc, B Besse
Revue Des Maladies Respiratoires
|
February 24, 2015
[Targeted therapies in non-small cell lung cancer in 2014]
C Leduc, B Besse
Bulletin Du Cancer
|
July 28, 2010
[Internet as a tool in oncology: critical analysis]
B Rousseau, B Besse,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2014
Pharmacogenomics in NSCLC: mostly unsexy but desperately needed
B Besse, M Reck
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Developments in the treatment of early NSCLC: when to use chemotherapy
B Besse, T Le Chevalier
Bulletin Du Cancer
|
December 26, 2009
[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value]
D Planchard, Y Loriot, B Besse
Bulletin Du Cancer
|
May 13, 2009
[Targeting of the AKT-mTOR pathway in head and neck and lung cancer]
S Vignot, S Haberer, B Besse
Page
of 14